It results in macrophage activation, release of pro-inflammatory cytokines (IL-1β, TNF-α), nitric oxide overproduction, and subsequent hypotension and endothelial dysfunction—phenomena previously observed in early clinical trials of cell-free Hb as an oxygen therapeutic. This evidence concerns the gene IL1B and endothelial dysfunction.